Unbiased AI-powered news
A new paper in Nature examines how the human RNA methyltransferase NSUN2 recognizes and modifies specific RNA sites. The research identifies structural and sequence features that determine substrate selectivity.
link.springer.comA research paper published in Nature describes the substrate selectivity of the human RNA m5C methyltransferase NSUN2. The study used cryoelectron microscopy to examine how the enzyme interacts with RNA substrates during different stages of its catalytic cycle.
NSUN2 adds 5-methylcytosine (m5C) modifications to various types of RNA. The paper states that dysregulation of NSUN2 is associated with cancers and neurological disorders.
The researchers found that RNA duplexes surrounding the modification site are important for NSUN2 activity. They identified a dual-stem structure containing the CNNRR motif at the 5′ end of the first stem as a minimized substrate that captures preferred features.
The study also examined how RNA structure facilitates NSUN2 activity at multiple tRNA positions. These structural elements help define which cytidines are modified.
The paper concludes that insights into substrate-specific enzymatic activity may help explain NSUN2-dependent methylation in biological and disease contexts. The work highlights roles of RNA structure and sequence in regulating RNA-modifying enzymes.
Single source — no framing comparison available.
Los Angeles TimesThe Defense Department reinstated required flu vaccinations for new recruits after an outbreak at Lackland Air Force Base sickened nearly 300 people. The reversal ends a policy that had made the shots optional for the first time in 70 years.
Nbc NewsSens. Kirsten Gillibrand and Eric Schmitt urged Defense Secretary Peter Hegseth to remove rules limiting Applied Behavior Analysis therapy under TRICARE. The letter followed an NBC News report detailing coverage denials for military families. It seeks to designate the therapy as…
upi.comThe legislation would let drugmakers issue retroactive rebates and impose new rules on hospitals and contract pharmacies. Separately, the Trump administration is considering Jeff Vacirca to lead the FDA.